RE:RE:RE:China News...Hi Ingi. I am an armchair investor as well. We have an easy role and are known for our impatience. Ha Ha. I wonder if Replicel has another partner in mind to show Shiseido that if they do not move then someone else will. I prefer Shiseido but if they are being difficult then time to move the bishop or knight into play. It is a bit of a dysfunctional chess match at the moment but they are still at the table. It certainly sends a message to Shiseido either directly or indirectly. Time will tell and perhaps even Replicel may not yet know that answer. YOFOTO is very promising and remember that they own a good chuck of Replicel and may yet buy us out which again would go badly for Shiseido if they are interested in controlling the Japanese market and beyond. Competition is a good thing for sure. Much better days may be ahead looking out 2 or 3 years though. I will continue to hold with that expectation. It was always a 3 to 5 year hold for me but I only got in about a year and half ago and while it has not performed to all my expectations I see potential for the goals to be fulfilled with in a very challenging finanical market for these med techs.
Cheers